Adam Steadman, MDD Options

Adam Steadman currently serves as CEO of MDD Options, a hybrid distribution and logistics organization focused on supporting start-up medical device companies as they enter commercialization in the USA. Among his previous roles, Adam was Global Head of Clinical Development for Medical Device and Diagnostics at one the world’s largest CROs, Syneos Health. In this role Adam was involved in studies conducted in many regions of the world, for a number of different regulatory pathways, for all classes of medical devices. As a subject matter expert, Adam has been involved as an author and presenter in a number of webinars, road shows, conferences and publications. Areas of expertise include clinical program development, EU MDR/IVDR and FDA IDE/NSR studies, SaMD and algorithm development. Adam has more than 18 years’ experience in Clinical Research Organizations in operations, finance and business development, prior to which time he qualified as a Chartered Accountant and held a number of leadership positions in other industries. Adam is based in the RTP area of North Carolina.